Company profile
MEDIPOST Inc.
- Industry
- Biotechnology Research
- Employees
- 39
- Headquarters
- Cambridge, Massachusetts
- LinkedIn followers
- 2,247
- Office locations
- 1
MEDIPOST Inc. company summary
MEDIPOST Inc. is a company in the Biotechnology Research industry, headquartered in Cambridge, Massachusetts. On LinkedIn the company has around 39 employees and 2,247 followers.
What technology does MEDIPOST Inc. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About MEDIPOST Inc.
MEDIPOST Inc. is a leading commercial-stage biotechnology company specializing in the development of umbilical cord-derived stem cell therapies to treat inflammation-driven degenerative diseases. The company's flagship product, CARTISTEM®, is the world's first allogeneic stem cell therapy, used to treat knee cartilage lesions caused by inflammation, approved in Korea in 2012 and used to treat over 30,000 patients. In the United States, CARTISTEM is entering late-stage development as a potential treatment for cartilage defects associated with knee osteoarthritis. In partnership with the Centre for Commercialization of Regenerative Medicine (CCRM), MEDIPOST has established OmniaBio, a cell and gene therapy contract development and manufacturing organization (CDMO) based in Hamilton, Ontario, to manufacture CARTISTEM.
Where is MEDIPOST Inc. located?
MEDIPOST Inc. lists 1 location.
Compare companies similar to MEDIPOST Inc.
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
MEDIPOST Inc. medi-post.com | Biotechnology Research | 39 | - | Cambridge, Massachusetts |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about MEDIPOST Inc.
What does MEDIPOST Inc. do?
MEDIPOST Inc. is a leading commercial-stage biotechnology company specializing in the development of umbilical cord-derived stem cell therapies to treat inflammation-driven degenerative diseases. The company's flagship product, CARTISTEM®, is the world's first allogeneic stem cell therapy, used to treat knee cartilage lesions caused by inflammation, approved in Korea in 2012 and used to treat over 30,000 patients. In the United States, CARTISTEM is entering late-stage development as a potential treatment for cartilage defects associated with knee osteoarthritis. In partnership with the Centre for Commercialization of Regenerative Medicine (CCRM), MEDIPOST has established OmniaBio, a cell and gene therapy contract development and manufacturing organization (CDMO) based in Hamilton, Ontario, to manufacture CARTISTEM.
How many employees does MEDIPOST Inc. have?
MEDIPOST Inc. has around 39 employees on LinkedIn.
Where is MEDIPOST Inc. headquartered?
MEDIPOST Inc. is headquartered in Cambridge, Massachusetts.
Build a lead list from companies like MEDIPOST Inc.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.